The complexities of benchmarking surgical complications in gynaecological oncology - (UK/GOG) mini review Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, April 07, 2016

The complexities of benchmarking surgical complications in gynaecological oncology - (UK/GOG) mini review



Blogger's Note: the patient safety communities will invariably (also) understand the role of campaigns such as 'sorry' and 'to err is human' which really is the underlying theme here

2016 - BJOG

 Author Information
  1. Division of Gynecologic Oncology, Women's Cancer Center of Nevada, Las Vegas, NV, USA
  1. Linked article: This is a mini commentary on Burnell M et al. To view this article visit http://dx.doi.org/10.1111/1471-0528.13994

     30 MAR 2016

    Burnell et al. (BJOG 2016; DOI: 10.1111/1471-0528.13994), in an attempt to establish benchmarks for potential use as future standards when evaluating quality of care provided by the individual physician, subspecialties, or hospital services, have undertaken a significant statistical endeavour using the data previously reported by Iyer et al. (Br J Cancer 2015;112:475–84). The authors’ use of complex statistical analyses has been tempered by their noting the shortcomings of the methods used and more importantly, their care to apply this analysis in a clinically meaningful context. Iyer et al. compiled intra-operative and postoperative complications as well as co-morbidities associated with surgery undertaken by gynaecological cancer services in ten major UK centres. These raw data have been used to construct benchmarks and to identify, with some limitations, institutions with higher and lower rates of complications, while not neglecting the institutional degree of surgical complexity. Given the relative paucity of data the authors were not able to extend this analysis to the individual surgeon.
    At first glance, establishment of benchmarks seems logical and important, as it contributes to the patients’ right to transparency regarding healthcare and a potential pathway to improve physician and institutional performance. In the USA, Gynecologic Oncology Group (GOG) trial results are not separated by institution, much less by the individual physician. Potentially this is problematic because these are publically funded trials and it is argued that the public has the right to know outcomes associated with specific institutions. Burnell et al. begin to address this issue. Complete transparency in healthcare sounds like a panacea, but there are potential risks associated with it. Specifically, it could lead to surgeons undertaking only low-risk procedures so as to lower their individual and institutional complication rates. This could become problematic in patients with ovarian cancer because rendering them free of disease requires highly complex surgery, which accordingly is associated with increased peri-operative complications, but also with improved overall survival. The authors do not address this most important of issues. Perhaps that institution with the highest rate of complications also has the highest overall survival; these two issues are inseparable.
    Using these data to identify individual surgeons or institutions in need of remedial training or instruction might be even more complicated. The premise of such benchmarking requires underlying honesty on the part of the surgeon and the institution and if the response to such reporting is seen as punitive, as opposed to educational or constructive, then it is doubtful that reporting will be forthright. This potential scenario requires a built-in mechanism for remedial training for surgeons who may fall below acceptable standards of care. Similarly, hospitals must be given an opportunity to correct any deficiencies. Accordingly, as these benchmarks are established, reporting of substandard performance should probably be limited to those failing to correct identified deficiencies.
    The last area that may be adversely affected by such reporting is resident education. Undoubtedly, if complications are going to be publically associated with individual surgeons, consultants will probably be less inclined to ‘turn cases over to the trainee’ and the long-term impact of this potentially outweighs any benefit associated with the transparency of reporting.
    In summary, this effort should be applauded, but application of this principle should be undertaken with considerable forethought.
    “for there is nothing either good or bad, but thinking makes it so”
    William Shakespeare

0 comments :

Post a Comment

Your comments?